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R
ecently, whole genome association (WGA) studies
have accelerated progress in the search for genetic
variations underlying the inheritance of complex
genetic diseases. Although population differences in allele
frequencies are usually small, these studies have
demonstrated the importance of accounting for population
differences in order to reduce false positive associations. Even
within a continental population, population stratiﬁcation—
ancestry differences between cases and controls—can cause
false associations at markers whose frequency differs across
subpopulations [1,2]. For example, in a recent WGA study of
rheumatoid arthritis in European Americans, markers in the
LCT and IRF4 genes would have been falsely implicated as
associated to disease without the application of methods to
control for stratiﬁcation [3]. Similar empirical examples of
population stratiﬁcation exist for other phenotypes, and
genetic risk has been reported to vary across Europe for a
wide range of diseases [4–8]. In general, investigators should
be alerted to consider population stratiﬁcation when WGA
data indicates that a particular marker shows a strong
frequency gradient across Europe.
Methods have already been developed to control for
population stratiﬁcation in the initial stage of WGA studies,
in which data from hundreds of thousands of markers is
generated [9,10]. However, controlling for stratiﬁcation is just
as important in replication studies in independent sample
sets, which will focus on a small number of markers. Similarly,
candidate gene studies and ﬁne mapping or sequencing
studies will also require attention to population differences.
Because a small number of candidate markers will not be
sufﬁciently informative for ancestry, and genotyping a large
number of markers is expensive, there is a need for small
panels of ancestry informative markers (AIMs) that can be
used to accurately infer ancestry [11]. We focus here on
European Americans, a structured population that is often
sampled in association studies.
Multiple studies have shown that the largest source of
population structure in European Americans involves a
north–south (or northwest–southeast) cline through Europe
[9,12,13]. However, subtler effects involving other regional or
ethnic differences can also contribute to stratiﬁcation. An
important question is which ancestries should be evaluated in
replication studies by genotyping of AIMs at additional cost.
The answer to this question will vary from study to study,
depending on factors such as the collection location of cases
and controls, the phenotype being studied, and
considerations of cost. For example, a study of a phenotype
with known ancestry differences, in which cases are collected
from a large city and controls are collected from throughout
the country, would be well-advised to deﬁne ancestry to the
fullest extent possible. On the other hand, a study of a
phenotype with no known ancestry differences, involving
cases and controls rigorously matched by location, might
choose to bypass the use of AIMs entirely. An intermediate
option would be to model only north–south ancestry,
addressing the single most likely source of stratiﬁcation at
partial cost, with some residual risk of stratiﬁcation.
Two research papers by our two groups in the current issue
of PLoS Genetics provide a broad assessment of European
American population structure, and also provide several sets
of AIMs for inferring ancestry in European Americans [3,4].
Our respective sets of AIMs were ascertained using different
pairs of populations, but have each been shown to be
effective in discerning the ancestries for which they were
ascertained. The Price et al. study analyzes WGA data from
the Affymetrix 500 K and Illumina 300 K platforms and
describes a set of 100 AIMs ascertained using northwest
versus southeast European ancestry (Price100) and a set of
200 AIMs ascertained using southeast European versus
Ashkenazi Jewish ancestry (Price200) [4]. The Tian et al. study
analyzes WGA data from the Illumina 300 K and 500 K
platforms and describes a set of 192 AIMs ascertained using
northern European versus Ashkenazi Jewish ancestry
(Tian192) and a set of 1,211 AIMs ascertained using Irish
versus other northern European ancestry (Tian1211) [3]. It
should be stressed that combined information from either a
very large set of markers or a set of highly specialized markers
is required to distinguish the ancestries of these genetically
very similar populations, whose real or perceived group
differences may often be dominated by environmental, social,
and cultural factors. Below, we outline the possible choices of
marker sets for inferring various ancestries. In each case, a
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components analysis can be applied to genotype data to
correct for stratiﬁcation.
To correct for stratiﬁcation along the north–south (or
northwest–southeast) cline, either the Price100 or Tian192
marker sets can be used. (The Tian192 markers, which were
ascertained using northern European versus Ashkenazi Jewish
ancestry, are effective in distinguishing north–south ancestry
because southern Europeans attain intermediate ancestry
values as compared to values at one extreme for northern
Europeans.) To correct for stratiﬁcation involving both
north–south and Ashkenazi Jewish ancestry, one option is to
use the Price100þPrice200 marker sets, which together
separate north, south, and Ashkenazi ancestry into three
distinct clusters. Another option is to use the Tian192 marker
set, which models these three ancestries along a single axis
and will be sufﬁcient in the case that the phenotype being
analyzed has intermediate values for southern European as
compared to northern European versus Ashkenazi Jewish
ancestry. Finally, to correct for stratiﬁcation involving a west–
east gradient within northern Europe (e.g., Irish versus other
northern European ancestry), the Tian1211 marker set is the
only set of AIMs available.
We note that the initial information from a WGA study can
help to determine the appropriate choice of AIMs for a
replication study. An important question is, are there
ancestry differences between cases and controls in the initial
WGA study—and if so, which ancestries contribute to this
effect, and do sets of AIMs correct for stratiﬁcation in the
WGA data as effectively as the complete set of WGA markers?
Of course, a caveat to such an approach is the requirement
that the cases and controls used for replication are
demographically matched to those used in the initial study.
It is also worth noting that for some studies the analysis of
population structure might precede WGA. Thus, depending
on the number of case and control samples and the cost of
prescreening with AIM panels, it may be advantageous to ﬁrst
match cases and controls for ancestry. This could improve the
power of the study, for two reasons. First, methods to correct
for stratiﬁcation in a scenario with poorly matched cases and
controls will lead to an inevitable loss of power in a WGA
study. Second, if a variant is more polymorphic or has higher
relative risk in samples of a particular ancestry, then a more
genetically homogeneous group of subjects (for example,
focusing on Ashkenazi Jewish ancestry [14]) may be more
likely to reveal that variant.
We caution that population stratiﬁcation is not the only
source of false positive associations in disease studies. In
particular, differences in DNA quality or laboratory treatment
between cases or controls may produce spurious signals that
will not be addressed by using AIMs [15]. Subtle instances of
differential bias will be difﬁcult to detect in studies involving a
small number of markers, but a possible diagnostic check is to
compare rates of missing data between cases and controls.
In conclusion, replication and candidate gene studies in
European Americans can now make use of AIMs for
examining north–south, Ashkenazi Jewish, and Irish ancestry.
Though European Americans could exhibit additional even
subtler population structure effects, these would contribute
much less strongly to stratiﬁcation and would require a
higher number of markers to discern, limiting their relevance
to AIM sets. Going forward, the widespread implementation
of AIMs may beneﬁt from specialized products on dedicated
platforms to reduce costs. Discussions are currently under
way to achieve this, and we anticipate that specialized AIM
products will be commercially available to the research
community in the near future. We also envision that the
increasing explosion of WGA data will aid the ascertainment
of AIM panels for a broader range of populations, beyond
European Americans. “
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